Endocrine Connections (Jul 2021)

T3 as predictor of mortality in any cause non-critically ill patients

  • Erika Biegelmeyer,
  • Iury Scanagata,
  • Laura Alves,
  • Murilo Reveilleau,
  • Fernando Pereira Schwengber,
  • Simone Magagnin Wajner

DOI
https://doi.org/10.1530/EC-21-0080
Journal volume & issue
Vol. 10, no. 8
pp. 852 – 860

Abstract

Read online

Background: Low T3 syndrome refers to a set of thyroid hormone metabolism alterations present in the disease state. A correlation between low T3 and poor clinical outcomes in the intensive care unit is more established. Nonetheless, studies on non-critically ill patients are few and controversial. Objective: To evaluate the prevalence and predictive value of low T3 levels on 30-day and 6-month mortality in non-critically ill patients. Secondary outcomes evaluated the length of hospital stay, overall mortality, and hospital readmission. Design: Prospective cohort study. Methods: A total of 345 consecutive patients from the Internal Medicine ward of a tertiary hospital in southern Brazil were included and followed from October 2018 to April 2019 (6 months). Levels of total serum T3 were measured weekly, from admission to discharge, and correlated with 30-day and 6-month mortality. Results: Prevalence of low T3 was 36.6%. Low T3 levels were associated with higher 30-day hospital mortality (15.1% vs 4.1%, P < 0.001) and higher 6-month overall mortality (31.7% vs 13.2%, P < 0.001). Total serum T3 at admission was an independent predictor of 30-day hospital mortality. Conclusion: Low T3 levels are a prevalent condition among non-critically ill patients, and this condition is associated with poor clinical outcomes in this population. Total serum T3 levels, alone or in association with other predictive scores, were demonstrated to be an easy and valuable tool for risk stratification and should be fur ther employed in this setting.

Keywords